Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination pharmaceutical product containing **capsicum oleoresin** (topical capsaicin) and **naproxen** (oral NSAID), primarily supplied as a co-packaged kit (tablet and cream) for the **temporary relief of minor aches and pains of muscles and joints** such as those associated with arthritis, tendonitis, bursitis, sprains, and strains. **Naproxen** is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis to provide anti-inflammatory, analgesic, and antipyretic effects. **Capsicum oleoresin** contains capsaicin, which is a selective agonist of the TRPV1 receptor in cutaneous sensory neurons; it produces local desensitization of pain fibers through prolonged receptor activation and local depletion of substance P, resulting in analgesia. This combination leverages systemic and local mechanisms to improve pain control[1][2][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsicum oleoresin + naproxen.